Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. The company is headquartered in Princeton, New Jersey and currently employs 4,427 full-time employees. The firm manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. The company provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, plastics and surgical reconstruction products, and others.
¿Quién es el CEO de Integra Lifesciences Holdings Corp?
Ms. Mojdeh Poul es el President de Integra Lifesciences Holdings Corp, se unió a la empresa desde 2025.
¿Qué tal es el rendimiento del precio de la acción IART?
El precio actual de IART es de $13.6, ha 下降 un 2.29% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Integra Lifesciences Holdings Corp?
Integra Lifesciences Holdings Corp pertenece a la industria Health Care y el sector es Health Care
¿Cuál es la capitalización bursátil de Integra Lifesciences Holdings Corp?
La capitalización bursátil actual de Integra Lifesciences Holdings Corp es $1.0B
¿Es Integra Lifesciences Holdings Corp una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 9 analistas han realizado calificaciones de análisis para Integra Lifesciences Holdings Corp, incluyendo 2 fuerte compra, 1 compra, 7 mantener, 4 venta, y 2 fuerte venta